| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 04/09/2009 | DE102007039899B3 Sensor zum Ermöglichen des Nachweises einer Substanz im Körper eines Lebewesens Sensor to allow the detection of a substance in the body of a living |
| 04/09/2009 | DE102007023714A1 Pneumatik- und/oder Fluidikmodul, Pneumatik und/oder Fluidiksystem und Verfahren zur Herstellung eines Pneumatik- und/oder Fluidikmoduls Pneumatic and / or fluidic, pneumatic and / or fluidic system and method for producing a pneumatic and / or fluidic module |
| 04/09/2009 | CA2739512A1 Granzyme a and granzyme b diagnostics |
| 04/09/2009 | CA2734139A1 Antibody therapy for use in the digestive tract |
| 04/09/2009 | CA2702025A1 A non-desensitizing mutant of the transient receptor potential trpm5 ion channel |
| 04/09/2009 | CA2701907A1 Optimized and defined method for isolation and preservation of precursor cells from human umbilical cord |
| 04/09/2009 | CA2701796A1 Laboratory-selected colonies of western corn rootworm with increased tolerance to maize containing event das-59122-7 and methods of use |
| 04/09/2009 | CA2701775A1 A novel bacteriocin from a new streptomyces species |
| 04/09/2009 | CA2701694A1 Antigen-binding proteins having specificity for human hepcidin |
| 04/09/2009 | CA2701602A1 Molecular adaptors |
| 04/09/2009 | CA2701580A1 Methods and apparatus for candling eggs via embryo heartbeat detection |
| 04/09/2009 | CA2701555A1 Systemic pro-hemostatic effect of sympathicomimetics with agonistic effects on .alpha.-adrenergic and/or .beta.-adrenergic receptors of the sympathetic nervous system, related to improved clot strength |
| 04/09/2009 | CA2701373A1 Use of the serological assay of the cytokine b-lymphocyte stimulator (blys) for the diagnosis, prognosis and the screening of therapeutic efficacy in immune-related diseases including organ-specific autoimmune diseases and transfusion reactions |
| 04/09/2009 | CA2701352A1 Collection and measurement of exhaled particles |
| 04/09/2009 | CA2701325A1 Analysis of conjugated metabolites of alcohol consumption |
| 04/09/2009 | CA2701172A1 Methods of treating neurological autoimmune disorders with cyclophosphamide |
| 04/09/2009 | CA2701048A1 Markers of endothelial cells and uses thereof |
| 04/09/2009 | CA2700831A1 Methods for detecting neutralizing antibodies for bone morphogenetic proteins |
| 04/09/2009 | CA2700457A1 Neural tumor stem cells and methods of use thereof |
| 04/09/2009 | CA2700416A1 Method and arrangement for unaffected material analyse |
| 04/09/2009 | CA2700011A1 Cc2d2a gene mutations associated with joubert syndrome and diagnostic methods for identifying the same |
| 04/09/2009 | CA2697988A1 Method of predicting drug-induced phospholipidosis |
| 04/09/2009 | CA2694843A1 Three-functional pseudo-peptidic reagent, and uses and applications thereof |
| 04/09/2009 | CA2694356A1 Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors |
| 04/09/2009 | CA2694154A1 Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors |
| 04/08/2009 | EP2045746A1 A device for supporting diagnosis of cancer and a device for predicting effects of anthracycline anticancer drugs |
| 04/08/2009 | EP2045604A1 Method for examining WT1-related disease |
| 04/08/2009 | EP2045603A1 Biosensors, uses and manufacture thereof |
| 04/08/2009 | EP2045602A1 Potency assay |
| 04/08/2009 | EP2045601A1 Use of microcarrier beads for detection and/or isolation of cells by flow cytometry and/or dielectrophoresis |
| 04/08/2009 | EP2045599A2 Ultra-sensitive magnetoreduction measurement system and method for determining the concentration of epitope-biomolecules |
| 04/08/2009 | EP2045597A1 Method for measuring hematocrit value of blood sample, method for measuring concentration of analyte in blood sample, sensor chip and sensor unit |
| 04/08/2009 | EP2045334A1 Decoding of array sensors with microspheres |
| 04/08/2009 | EP2045332A1 Proteome-wide quantification of small molecule binding to cellular target proteins |
| 04/08/2009 | EP2045328A1 Peptide and nucleotide sequences of anisakis spp., antibodies that recognise said sequences and uses of same |
| 04/08/2009 | EP2045326A1 Method for identifying the interaction partner of an active agent |
| 04/08/2009 | EP2045264A2 Novel pH- and anion concentration-responsive GFP mutant, a chimeric protein comprising such a mutant and a method for the combined assaying of the pH and anion concentration |
| 04/08/2009 | EP2045261A1 Chlamydia pneumoniae antigenic polypeptides |
| 04/08/2009 | EP2045252A2 Derivatives of 1,2-dihydro-7-hydroxyquinolines containing fused rings |
| 04/08/2009 | EP2044955A2 Methods for detecting and inhibiting angiogenesis |
| 04/08/2009 | EP2044444A1 Methods for assaying percentage of glycated hemoglobin |
| 04/08/2009 | EP2044443A2 Peptide antibody depletion and its application to mass spectrometry sample preparation |
| 04/08/2009 | EP2044442A1 Prognostic marker for breast cancer and composition for inducing obesity comprising hccr-1 |
| 04/08/2009 | EP2044441A2 Method for controlling the therapy of patients suffering from cardiac insufficiency by means of in vitro determination of threshold values of vasoactive peptides |
| 04/08/2009 | EP2044440A1 Method of detecting interactions between protein components |
| 04/08/2009 | EP2044439A2 Methods for determining a prognosis of colorectal cancer |
| 04/08/2009 | EP2044438A2 Arrangement for on-line measurements on cells |
| 04/08/2009 | EP2044437A2 Methods for detecting molecular complexes |
| 04/08/2009 | EP2044436A2 Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders |
| 04/08/2009 | EP2044435A2 Modulators of scarb-1 in the treatment of acne or of hyperseborrhoea |
| 04/08/2009 | EP2044434A2 Methods and materials for observing apoptosis by detecting fragments of clathrin-pathway components |
| 04/08/2009 | EP2044433A2 Embedded data dna sequence security system |
| 04/08/2009 | EP2044432A2 Minimizing effects of dye crosstalk |
| 04/08/2009 | EP2044431A2 Computer systems and methods for selecting subjects for clinical trials |
| 04/08/2009 | EP2044430A2 Method and arrangement for determining the yarn quality and/or spool quality of a running thread based on laser-doppler anemometry |
| 04/08/2009 | EP2044429A2 Systems and methods for monitoring travel conditions |
| 04/08/2009 | EP2044426A1 Method for assessing a state of a document of value with regard to limpness using ultrasound, and means for carrying out the method |
| 04/08/2009 | EP2044422A1 Method for determining a characteristic parameter of a crp specimen |
| 04/08/2009 | EP2044416A1 Attraction and repulsion of magnetic of magnetizable objects to and from a sensor surface |
| 04/08/2009 | EP2044402A2 Assay particle concentration and imaging apparatus and method |
| 04/08/2009 | EP2044246A2 Dominant negative ligand drug discovery system |
| 04/08/2009 | EP2044216A2 Prostate specific transcripts and the use thereof for prostate cancer therapeutics and diagnostics |
| 04/08/2009 | EP2044215A1 Methods and nucleic acids for analyses for cellular proliferative disorders |
| 04/08/2009 | EP2044212A2 Methods for identifying patients with increased risk of an adverse cardiovascular event |
| 04/08/2009 | EP2044209A1 Diagnostic strip coding system with conductive layers |
| 04/08/2009 | EP2044122A2 Antagonist antibody against epha2 for the treatment of cancer |
| 04/08/2009 | EP2044121A2 Glyco-enqineered antibodies |
| 04/08/2009 | EP2044119A1 Cancerous disease modifying antibodies |
| 04/08/2009 | EP2043696A2 Methods and compositions for targeting gc1qr/p32 |
| 04/08/2009 | EP2043687A2 Anti-amyloid antibodies, compositions, methods and uses |
| 04/08/2009 | EP2043666A2 Activated myeloid cells for promoting tissue repair and detecting damaged tissue |
| 04/08/2009 | EP2043518A1 Gas sensor |
| 04/08/2009 | EP2043514A2 Multielectrode array and method of manufacturing the same |
| 04/08/2009 | EP2043434A2 Campylobacter pilus protein, compositions and methods |
| 04/08/2009 | EP2043428A2 Modulators of rnf5 and uses thereof |
| 04/08/2009 | EP2002261A4 Methods and compositions for obtaining and using biologically active multi-protein complexes |
| 04/08/2009 | EP1996937A4 Genetic packages and uses thereof |
| 04/08/2009 | EP1952157A4 Lung cancer diagnostic assay |
| 04/08/2009 | EP1946106A4 Methods for indentification of inhibitors of enzyme activity |
| 04/08/2009 | EP1934604A4 Materials and methods for assaying for glyoxylate |
| 04/08/2009 | EP1907858A4 Compositions and methods for treating and diagnosing cancer |
| 04/08/2009 | EP1866443A4 Screening using polarization anisotropy in fret emissions |
| 04/08/2009 | EP1846768A4 Use of he4 and other biochemical markers for assessment of ovarian cancers |
| 04/08/2009 | EP1846760A4 Rapid comparative genome hybridization |
| 04/08/2009 | EP1774020A4 Phage microarray profiling of the humoral response to disease |
| 04/08/2009 | EP1738171B1 Fluorescence resonance energy transfer enzyme substrates |
| 04/08/2009 | EP1725867A4 Analysis element for use in method of testing specimen |
| 04/08/2009 | EP1673393B1 Methods, kits, and compositions for the development and use of monoclonal antibodies specific to antigens of low immunogenicity |
| 04/08/2009 | EP1644730B1 Susceptometer for non-invasive iron level measurement in a body |
| 04/08/2009 | EP1570260B1 Probe for determination of oxygen activity in metal melts and method for its production |
| 04/08/2009 | EP1482965B1 Method to control tumor progression and invasiveness |
| 04/08/2009 | EP1476468B9 Human monoclonal antibody fab fragments directed against hcv e2 glycoprotein and endowed with in vitro neutralizing activity |
| 04/08/2009 | EP1344062B1 Support for determining an analyte comprising a selective spectral filter |
| 04/08/2009 | EP1299426B1 Improved microgels and films |
| 04/08/2009 | EP1250353B1 P21 derived peptides capable of inhibiting cdk/cyclin complexes |
| 04/08/2009 | EP1151143B1 Selection of proteins using rna-protein fusions |
| 04/08/2009 | EP1117832B1 Detection of nucleic acid polymorphism |
| 04/08/2009 | EP1020532B1 Method for assaying biological specimens for substances contained in the components thereof and reagent to be used in this method |
| 04/08/2009 | EP0877758B1 PURIFIED SR-p70 PROTEIN |
| 04/08/2009 | CN201218813Y Rotation type automatic sample injector |